Silence the expression of Mn-SOD sensitized CNE1 cells to radiation, suggesting that combination of Mn-SOD gene silencing and radiotherapy may improve clinical outcome for NPC therapy [55]. The gene discussed is SOD2; the disease is nasopharyngeal carcinoma.